Skip to main content
. 2017 Aug 23;8:566. doi: 10.3389/fphar.2017.00566

FIGURE 2.

FIGURE 2

Effect of combined verapamil (VER) 5 mg/kg and scopolamine (SCOP) (1 or 30 mg/kg), administered i.p., immediately after the acquisition trial, on the 48 h retention trial, in the passive avoidance task in conditions of 180 (A), 300 (B), and 540 s (C) cut-off latency. Data are presented as mean ± SEM. C-compared to SCOP-1; p < 0.05.